Free Trial
NASDAQ:AMTX

Aemetis (AMTX) Stock Price, News & Analysis

Aemetis logo
$4.14 +0.27 (+6.98%)
(As of 03:00 PM ET)

About Aemetis Stock (NASDAQ:AMTX)

Key Stats

Today's Range
$3.88
$4.22
50-Day Range
$2.29
$4.62
52-Week Range
$2.10
$7.03
Volume
744,758 shs
Average Volume
806,658 shs
Market Capitalization
$205.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.95
Consensus Rating
Moderate Buy

Company Overview

Aemetis, Inc. operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products. In addition, it produces and sells ethanol; and wet distillers grains, distillers corn oil, and condensed distillers solubles to dairies and feedlots as animal feed. Further, the company markets and supplies USP alcohol and hand sanitizer; and produces renewable natural gas, as well as distilled biodiesel from various vegetable oil and animal waste feedstocks. Additionally, it researches and develops conversion technologies using waste feedstocks to produce biofuels and biochemicals. Furthermore, it sells biodiesel primarily to government oil marketing companies. Aemetis, Inc. is headquartered in Cupertino, California.

Aemetis Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
40th Percentile Overall Score

AMTX MarketRank™: 

Aemetis scored higher than 40% of companies evaluated by MarketBeat, and ranked 193rd out of 263 stocks in the oils/energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Aemetis has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Aemetis has only been the subject of 2 research reports in the past 90 days.

  • Read more about Aemetis' stock forecast and price target.
  • Earnings Growth

    Earnings for Aemetis are expected to grow in the coming year, from ($2.02) to ($0.59) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Aemetis is -1.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Aemetis is -1.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Aemetis' valuation and earnings.
  • Percentage of Shares Shorted

    13.57% of the outstanding shares of Aemetis have been sold short.
  • Short Interest Ratio / Days to Cover

    Aemetis has a short interest ratio ("days to cover") of 12.1, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Aemetis has recently decreased by 3.43%, indicating that investor sentiment is improving.
  • Dividend Yield

    Aemetis does not currently pay a dividend.

  • Dividend Growth

    Aemetis does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    13.57% of the outstanding shares of Aemetis have been sold short.
  • Short Interest Ratio / Days to Cover

    Aemetis has a short interest ratio ("days to cover") of 12.1, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Aemetis has recently decreased by 3.43%, indicating that investor sentiment is improving.
  • News Sentiment

    Aemetis has a news sentiment score of 0.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Oils/Energy companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Aemetis this week, compared to 2 articles on an average week.
  • Search Interest

    10 people have searched for AMTX on MarketBeat in the last 30 days. This is an increase of 233% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added Aemetis to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Aemetis insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    15.90% of the stock of Aemetis is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 27.02% of the stock of Aemetis is held by institutions.

  • Read more about Aemetis' insider trading history.
Receive AMTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aemetis and its competitors with MarketBeat's FREE daily newsletter.

AMTX Stock News Headlines

HC Wainwright Reiterates Buy Rating for Aemetis (NASDAQ:AMTX)
Breaking News: Tesla headed to $500…
That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla.
Preview: Aemetis's Earnings
Aemetis Reports Revenues of $81 Million for the Third Quarter 2024
Aemetis, Inc. (AMTX) Q3 2024 Earnings Call Transcript
See More Headlines

AMTX Stock Analysis - Frequently Asked Questions

Aemetis' stock was trading at $5.24 at the beginning of 2024. Since then, AMTX stock has decreased by 24.0% and is now trading at $3.98.
View the best growth stocks for 2024 here
.

Aemetis, Inc. (NASDAQ:AMTX) issued its earnings results on Tuesday, November, 12th. The specialty chemicals company reported ($0.38) earnings per share for the quarter, topping the consensus estimate of ($0.47) by $0.09. The specialty chemicals company had revenue of $81.44 million for the quarter, compared to analysts' expectations of $77.79 million.

Aemetis' top institutional shareholders include Geode Capital Management LLC (1.86%), State Street Corp (1.41%), Stifel Financial Corp (0.84%) and Charles Schwab Investment Management Inc. (0.18%). Insiders that own company stock include Naomi Louise Boness, John R Block and Timothy Alan Simon.
View institutional ownership trends
.

Shares of AMTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aemetis investors own include Waste Connections (WCN), DiamondRock Hospitality (DRH), American Water Works (AWK), The RMR Group (RMR), AUO (AUOTY), iShares Micro-Cap ETF (IWC) and Voyager Therapeutics (VYGR).

Company Calendar

Last Earnings
11/12/2024
Today
11/21/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
3/06/2025

Industry, Sector and Symbol

Industry
Industrial organic chemicals
Sub-Industry
Chemicals
Current Symbol
NASDAQ:AMTX
Employees
160
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$12.95
High Stock Price Target
$28.00
Low Stock Price Target
$3.50
Potential Upside/Downside
+215.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

Net Income
$-46,420,000.00
Pretax Margin
-32.43%

Debt

Sales & Book Value

Annual Sales
$186.72 million
Book Value
($5.21) per share

Miscellaneous

Free Float
41,827,000
Market Cap
$204.43 million
Optionable
Optionable
Beta
1.23

Social Links

7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

This page (NASDAQ:AMTX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners